Guizhou Bailing Group Pharmaceutical Co Ltd Financial Flexibility Index
Guizhou Bailing Group Pharmaceutical Co Ltd financial flexibility index. Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥298.34 Million (operating CF CN¥294.76 Million minus capex CN¥3.59 Million) represents 0% of total liabilities (CN¥3.00 Billion). See Guizhou Bailing Group Pharmaceutical Co (002424) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
Financial flexibility index of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Guizhou Bailing Group Pharmaceutical Co Ltd across 19 annual periods. Check 002424 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Guizhou Bailing Group Pharmaceutical Co Ltd Financial Flexibility Index by Year (2007–2025)
Guizhou Bailing Group Pharmaceutical Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Guizhou Bailing Group Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Guizhou Bailing Group Pharmaceutical Co .
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥873.96 Million | CN¥748.72 Million | CN¥3.02 Billion | ▲ +2129.6% |
| 2024 | 0.01x | CN¥51.04 Million | CN¥9.02 Million | CN¥3.94 Billion | ▼ -78.4% |
| 2023 | 0.06x | CN¥229.89 Million | CN¥125.77 Million | CN¥3.82 Billion | ▼ -69.5% |
| 2022 | 0.20x | CN¥570.60 Million | CN¥502.15 Million | CN¥2.90 Billion | ▼ -33.6% |
| 2021 | 0.30x | CN¥750.65 Million | CN¥324.92 Million | CN¥2.53 Billion | ▲ +187.1% |
| 2020 | 0.10x | CN¥321.80 Million | CN¥231.78 Million | CN¥3.11 Billion | ▼ -48.9% |
| 2019 | 0.20x | CN¥589.32 Million | CN¥467.41 Million | CN¥2.91 Billion | ▲ +1559.9% |
| 2018 | -0.01x | CN¥-28.43 Million | CN¥-157.45 Million | CN¥2.05 Billion | ▼ -108.4% |
| 2017 | 0.17x | CN¥224.57 Million | CN¥79.88 Million | CN¥1.36 Billion | ▼ -69.0% |
| 2016 | 0.53x | CN¥625.95 Million | CN¥466.62 Million | CN¥1.17 Billion | ▲ +16.2% |
| 2015 | 0.46x | CN¥534.27 Million | CN¥413.23 Million | CN¥1.16 Billion | ▲ +13.8% |
| 2014 | 0.40x | CN¥492.32 Million | CN¥395.83 Million | CN¥1.22 Billion | ▲ +137.2% |
| 2013 | 0.17x | CN¥230.50 Million | CN¥141.76 Million | CN¥1.35 Billion | ▲ +2.3% |
| 2012 | 0.17x | CN¥199.68 Million | CN¥19.52 Million | CN¥1.20 Billion | ▼ -54.5% |
| 2011 | 0.37x | CN¥394.98 Million | CN¥201.90 Million | CN¥1.08 Billion | ▲ +223.7% |
| 2010 | -0.30x | CN¥-281.99 Million | CN¥-447.68 Million | CN¥952.49 Million | ▼ -189.6% |
| 2009 | 0.33x | CN¥147.22 Million | CN¥125.31 Million | CN¥445.48 Million | ▲ +485.3% |
| 2008 | -0.09x | CN¥-27.51 Million | CN¥-40.42 Million | CN¥320.72 Million | ▲ +63.2% |
| 2007 | -0.23x | CN¥-73.70 Million | CN¥-79.37 Million | CN¥315.87 Million | — |